Upper Tract Urothelial Carcinoma (UTUC)Symptoms, Doctors, Treatments, Advances & More
Learn About Upper Tract Urothelial Carcinoma (UTUC)
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Johns Hopkins Health Care & Surgery Center - Green Spring Station, Lutherville
Nirmish Singla is an Oncologist practicing medicine in Lutherville, Maryland. Dr. Singla is rated as an Elite provider by MediFind in the treatment of Upper Tract Urothelial Carcinoma (UTUC). He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Upper Tract Urothelial Carcinoma (UTUC), Renal Cell Carcinoma (RCC), Urothelial Cancer, Nephrectomy, and Orchiectomy. Dr. Singla is board certified in American Board Of Urology.
Jefferson Urology – Honickman Center
Scott Hubosky is a Urologist practicing medicine in Philadelphia, Pennsylvania. Dr. Hubosky is rated as an Elite provider by MediFind in the treatment of Upper Tract Urothelial Carcinoma (UTUC). He is also highly rated in 28 other conditions, according to our data. His clinical expertise encompasses Upper Tract Urothelial Carcinoma (UTUC), Urothelial Cancer, Kidney Stones, Ureteroscopy, and Endoscopy. Dr. Hubosky is board certified in Urology. Dr. Hubosky is currently accepting new patients.
Skip Viragh Outpatient Cancer Center
Dr. Jean Hoffman-Censits is a genitourinary cancer specialist in Baltimore, caring for patients with urothelial cancers of the bladder and upper tract. She serves as co-leader of the Women’s Bladder Cancer Program in the Greenberg Bladder Cancer Institute at the Johns Hopkins University School of Medicine. Dr. Hoffman-Censits received her undergraduate degree in neuroscience from Trinity College. She earned her M.D. degree from the Sidney Kimmel Medical College of Thomas Jefferson University. She completed her residency at Thomas Jefferson University Hospital and performed a fellowship in hematology and oncology at Temple University Medical Center. She joined the Johns Hopkins faculty in 2018. Dr. Hoffman-Censits's research interests focus on urothelial cancers. Her clinical research has helped identify urothelial cancer sub-types and establish new treatments for bladder and upper tract urothelial cancers. She is a member of the American Medical Association, the American Society of Clinical Oncology, the American Urological Association and the Society for Immunotherapy of Cancer. Dr. Hoffman is rated as an Elite provider by MediFind in the treatment of Upper Tract Urothelial Carcinoma (UTUC). She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses Urothelial Cancer, Bladder Cancer, Muscle Invasive Bladder Cancer, Bladder Reconstruction, and Nephrectomy. Dr. Hoffman is board certified in American Board Of Internal Medicine.
Summary: A Phase 2A/B study of Dabogratinib (TYRA-300) in Low Grade Upper Tract Urothelial Carcinoma
Summary: This is a single-center, prospective, non-interventional observational cohort study designed to establish a structured recurrence monitoring platform in Korean patients with high-grade non-metastatic upper tract urothelial carcinoma (UTUC). Eligible adult patients scheduled to receive neoadjuvant chemotherapy followed by radical nephroureterectomy will undergo circulating tumor DNA (ctDNA) samplin...